AAAAAA
Results:
1-8
|
Results: 8
Authors:
Vauquelin, G
Morsing, P
Fierens, FLP
De Backer, JP
Vanderheyden, PML
Citation: G. Vauquelin et al., A two-state receptor model for the interaction between angiotensin II type1 receptors and non-peptide antagonists, BIOCH PHARM, 61(3), 2001, pp. 277-284
Authors:
Thorup, C
Kurkus, J
Morsing, P
Ollerstam, A
Persson, AEG
Citation: C. Thorup et al., Impaired effect by NO synthase inhibition on tubuloglomerular feedback in rats after chronic renal denervation, ACT PHYSL S, 168(1), 2000, pp. 89-93
Authors:
Arendshorst, WJ
Morsing, P
Navar, LG
Citation: Wj. Arendshorst et al., Function and clinical perspectives of angiotensin II subtype 1 (AT(1)) receptors - Introduction, J AM S NEPH, 10, 1999, pp. S1-S1
Authors:
Bennai, F
Morsing, P
Paliege, A
Ketteler, M
Mayer, B
Tapp, R
Bachmann, S
Citation: F. Bennai et al., Normalizing the expression of nitric oxide synthase by low-dose AT(1) receptor antagonism parallels improved vascular morphology in hypertensive rats, J AM S NEPH, 10, 1999, pp. S104-S115
Authors:
Pollock, DM
Morsing, P
Citation: Dm. Pollock et P. Morsing, Combined treatment with ibuprofen and the AT(1) receptor antagonist candesartan in young spontaneously hypertensive rats, J AM S NEPH, 10, 1999, pp. S116-S119
Authors:
Brannstrom, K
Morsing, P
Arendshorst, WJ
Citation: K. Brannstrom et al., Candesartan normalizes exaggerated tubuloglomerular feedback activity in young spontaneously hypertensive rats, J AM S NEPH, 10, 1999, pp. S213-S219
Authors:
Morsing, P
Citation: P. Morsing, Candesartan: A new-generation angiotensin II AT(1) receptor blocker: Pharmacology, antihypertensive efficacy, renal function, and renoprotection, J AM S NEPH, 10, 1999, pp. S248-S254
Authors:
Morsing, P
Adler, G
Brandt-Eliasson, U
Karp, L
Ohlson, K
Renberg, L
Sjoquist, PO
Abrahamsson, T
Citation: P. Morsing et al., Mechanistic differences of various AT(1)-receptor blockers in isolated vessels of different origin, HYPERTENSIO, 33(6), 1999, pp. 1406-1413
Risultati:
1-8
|